Archives for August 2016

Medication Errors–A Threat To Patient Safety

Source: Colorcon

By Jay Anbil and Steve Yoder

Medical prescription drug errors by doctors, pharmacists and patients account for 1.5 million incidences of sickness, injuries or deaths in the U.S. each year. Thirty percent of these unnecessary adverse events are attributed to human errors in identifying drugs and dosages. In fact, more people die from adverse drug events each year than from highway accidents, breast cancer, or complications from HIV.

Mylan Offers Patient Discounts to Lower Price of EpiPen

Mylan is cutting out-of-pocket costs for its EpiPen after members of Congress and presidential hopeful Hillary Clinton lambasted the company for hiking the price of the emergency allergy therapy.

Sagent recalls more of its antibiotics manufactured in India

Sagent Pharmaceuticals ($SGNT) is widening its recall of antibiotics manufactured by one of its India-based contractors after a customer complained that small, dark particulate matter were found in the solution after it was reconstituted.

ACI’s keeps you, and your research safer – Aseptic Containment Isolators do a superior job!

August 24 2016.   Aseptic Enclosures.  St. Louis, MO.   The purpose of this post is to help you evaluate the type of hood you do your sterile and containment work in.  It is our strong contention that much more laboratory work should be done in a class III ACI a.k.a.  Glove-box, Isolator, etc.  They provide superior protection for you and your research and are valuable, even if your research is not BSL4.  Your science, and your health are very important; taking shortcuts relative to the protection of either can have significant short and long-term ramifications.  Unfortunately, in our thousands of laboratory audits, we have found that procedural errors relative to aseptic containment work seem to be all too frequent.  We hope you find this content useful and informative…and of course, if we can help you with any equipment that will provide you and your science with a superior level of protection, please let us know.

Naira devaluation causing drug shortage – Pharmacists

Nigerian pharmacists, under the aegis of the Association of Hospital and Administrative Pharmacists of Nigeria, have lamented the declining value of naira, saying it poses a threat to the delivery of health care in the country.

FDA Seeks Input on OTC Infectious Disease Testing

The benefits and risks of over-the-counter tests for infectious diseases including respiratory infections, Group A Streptococcus and certain sexually transmitted infections (STIs) — and how the FDA should evaluate them — is the topic for an agency advisory committee meeting to be held Tuesday.

Chemo drug in pregnancy may cause early menopause in daughters

Etoposide works by blocking an enzyme, which is necessary forcancer cells to divide and grow into two new cells. If this enzyme is blocked, the cell’s DNA becomes tangled, and the cell can no longer divide.

Compounding Pharmacists Unhappy With New FDA Guidance Documents

The Food and Drug Administration (FDA) is slowly issuing multiple guidances for state-licensed community, hospital, and federally licensed outsourcing compounding pharmacies—and raising hackles in doing so. The agency issued three final “interim” guidances in June,13 which followed its three draft guidances in April.46Those guidances cover issues such as central compounding pharmacies in health systems, ingredients that can be used in compounded drugs, and whether community pharmacies can sell small amounts to physicians without getting individual prescriptions for each dose.

The FDA just greenlit releasing mutant Zika-killing mosquitoes in Florida

Our sci-fi future just got a whole lot closer to becoming a reality, after the Food and Drug Administration gave the okay to a field trial that would release genetically modified Zika-killing mosquitoes in the Florida Keys.

Rock star cancer treatment is being scrutinized after clinical trial deaths

Sometimes, a cancer patient just knows when enough is enough. Robert Legaspi, 27, was diagnosed with acute lymphoblastic leukemia (ALL) when he was 9 years old. Since then, his cancer has recurred several times. The chemotherapy regimens have been long and brutal, and it’s taken two years each time for him to get back into remission.